{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:46:36Z","timestamp":1791405996393,"version":"4.3.3"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1093\/brain\/awr298","type":"journal-article","created":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T20:30:44Z","timestamp":1322339444000},"page":"181-189","source":"Crossref","is-referenced-by-count":286,"title":["Blood\u2013brain barrier P-glycoprotein function in Alzheimer's disease"],"prefix":"10.1093","volume":"135","author":[{"given":"Dani\u00eblle M. E.","family":"van Assema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lubberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje M.","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile F. I.","family":"Comans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikie J.","family":"Hoetjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelleke","family":"Tolboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N. M.","family":"van Berckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,25]]},"reference":[{"key":"key\n\t\t\t\t20170624051930_awr298-B1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0041-008X(96)80035-4","article-title":"Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein","volume":"141","author":"Bain","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/ctrv.2000.0194","article-title":"The blood\u2013brain barrier and oncology: new insights into function and modulation","volume":"26","author":"Bart","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t20170624051930_awr298-B5","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S1053-8119(03)00405-1","article-title":"Quantitative assessment of P-glycoprotein function in the rat blood\u2013brain barrier by distribution volume of [11C]verapamil measured with PET","volume":"20","author":"Bart","year":"2003","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170624051930_awr298-B6","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","article-title":"Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration","volume":"30","author":"Bartels","year":"2009","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20170624051930_awr298-B7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.11.007","article-title":"Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease","volume":"14","author":"Bartels","year":"2008","journal-title":"Parkinsonism Relat D"},{"key":"key\n\t\t\t\t20170624051930_awr298-B8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood\u2013brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA","volume":"115","author":"Bartels","year":"2008","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170624051930_awr298-B9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00228-009-0709-5","article-title":"Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET","volume":"65","author":"Bauer","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170624051930_awr298-B11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B12","first-page":"1614","article-title":"Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association","volume":"38","author":"Brix","year":"1997","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170624051930_awr298-B13","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood\u2013brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170624051930_awr298-B14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMra040223","article-title":"Alzheimer's disease","volume":"351","author":"Cummings","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170624051930_awr298-B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/jcbfm.1993.5","article-title":"Spectral analysis of dynamic PET studies","volume":"13","author":"Cunningham","year":"1993","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170624051930_awr298-B16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","article-title":"Potential role of ABC transporters as a detoxification system at the blood-CSF barrier","volume":"56","author":"de Lange","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"key\n\t\t\t\t20170624051930_awr298-B17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood\u2013brain barrier: implication for therapies in Alzheimer's disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"key\n\t\t\t\t20170624051930_awr298-B18","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","article-title":"RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood\u2013brain barrier","volume":"35","author":"Deane","year":"2004","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20170624051930_awr298-B19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720507780362245","article-title":"Role of the blood\u2013brain barrier in the pathogenesis of Alzheimer's disease","volume":"4","author":"Deane","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"key\n\t\t\t\t20170624051930_awr298-B20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1006\/bbrc.2001.4312","article-title":"Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms","volume":"281","author":"Demeule","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170624051930_awr298-B21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10611860310001648248","article-title":"Classification analysis of P-glycoprotein substrate specificity","volume":"11","author":"Didziapetris","year":"2003","journal-title":"J Drug Target"},{"key":"key\n\t\t\t\t20170624051930_awr298-B22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B23","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170624051930_awr298-B24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental State\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"key\n\t\t\t\t20170624051930_awr298-B26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2004.06.002","article-title":"Importance of P-glycoprotein at blood-tissue barriers","volume":"25","author":"Fromm","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"key\n\t\t\t\t20170624051930_awr298-B27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1006\/nimg.1998.0379","article-title":"Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET","volume":"8","author":"Gunn","year":"1998","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170624051930_awr298-B28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t20170624051930_awr298-B29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood\u2013brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B30","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1177\/00912700122013255","article-title":"P-glycoprotein at the blood\u2013brain barrier and analysis of drug transport with positron-emission tomography","author":"Hendrikse","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B31","first-page":"2411","article-title":"A new in vivo method to study P-glycoprotein transport in tumors and the blood\u2013brain barrier","volume":"59","author":"Hendrikse","year":"1999","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170624051930_awr298-B32","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170624051930_awr298-B33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","article-title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","volume":"62","author":"Johnson","year":"2007","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B34","doi-asserted-by":"crossref","first-page":"T83","DOI":"10.1016\/j.neuroimage.2006.04.071","article-title":"Effects of MR scanner type, scanning sequence and segmentation algorithm on MR-based partial volume corrections of [11C](R)-PK11195 studies","volume":"32","author":"Kloet","year":"2006","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170624051930_awr298-B35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B36","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.jcbfm.9600092","article-title":"Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies","volume":"25","author":"Kropholler","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170624051930_awr298-B37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","article-title":"MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides\u2013implications for the mechanisms of Abeta clearance at the blood\u2013brain barrier","volume":"17","author":"Kuhnke","year":"2007","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"beta-Amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170624051930_awr298-B39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170624051930_awr298-B40","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1023\/B:PHAM.0000036905.82914.8e","article-title":"Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders","volume":"21","author":"Lee","year":"2004","journal-title":"Pharm Res"},{"key":"key\n\t\t\t\t20170624051930_awr298-B41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0b013e318221acee","article-title":"Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B","volume":"77","author":"Lee","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170624051930_awr298-B42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1124\/jpet.105.088328","article-title":"In vivo evaluation of P-glycoprotein function at the blood\u2013brain barrier in nonhuman primates using [11C]verapamil","volume":"316","author":"Lee","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170624051930_awr298-B43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"Loscher","year":"2005","journal-title":"NeuroRx"},{"key":"key\n\t\t\t\t20170624051930_awr298-B44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.jcbfm.9600349","article-title":"Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET","volume":"27","author":"Lubberink","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170624051930_awr298-B45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nucmedbio.2004.06.007","article-title":"Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood\u2013brain barrier: kinetics and metabolism in the rat","volume":"32","author":"Luurtsema","year":"2005","journal-title":"Nucl Med Biol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0969-8051(03)00078-7","article-title":"R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation","volume":"30","author":"Luurtsema","year":"2003","journal-title":"Nucl Med Biol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B47","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jlcr.632","article-title":"Fully automated high yield synthesis of (R)- and (S)-[C-11]verapamil for measuring P-glycoprotein function with positron emission tomography","volume":"45","author":"Luurtsema","year":"2002","journal-title":"J Labelled Compds Radiopharm"},{"key":"key\n\t\t\t\t20170624051930_awr298-B48","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t20170624051930_awr298-B49","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170624051930_awr298-B50","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2967\/jnumed.108.059162","article-title":"Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans","volume":"50","author":"Muzi","year":"2009","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170624051930_awr298-B51","doi-asserted-by":"crossref","first-page":"$52","DOI":"10.1016\/j.neuroimage.2010.04.233","article-title":"Time Course of specific [11C]PIB and [18F]FDDNP binding: paired studies in patients with Alzheimer's disease, mild cognitive impairment and healthy controls","volume":"52","author":"Ossenkoppele","year":"2010","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170624051930_awr298-B52","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170624051930_awr298-B53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clpt.2005.01.022","article-title":"Imaging P-glycoprotein transport activity at the human blood\u2013brain barrier with positron emission tomography","volume":"77","author":"Sasongko","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170624051930_awr298-B54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-Glycoprotein, a gatekeeper in the blood\u2013brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"key\n\t\t\t\t20170624051930_awr298-B55","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"Beta-amyloid, blood vessels, and brain function","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20170624051930_awr298-B56","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroimage.2004.10.017","article-title":"MR-based automatic delineation of volumes of interest in human brain PET images using probability maps","volume":"24","author":"Svarer","year":"2005","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170624051930_awr298-B57","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jnnp.2009.194779","article-title":"Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images","volume":"81","author":"Tolboom","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170624051930_awr298-B58","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00259-009-1129-6","article-title":"Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease","volume":"36","author":"Tolboom","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20170624051930_awr298-B59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2967\/jnumed.108.056499","article-title":"Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET","volume":"50","author":"Tolboom","year":"2009","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170624051930_awr298-B60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clpt.2006.02.004","article-title":"Effect of age on functional P-glycoprotein in the blood\u2013brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography","volume":"79","author":"Toornvliet","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170624051930_awr298-B61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.110.079608","article-title":"Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening","volume":"52","author":"Tournier","year":"2011","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170624051930_awr298-B62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3956(03)00022-0","article-title":"abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice","volume":"37","author":"Uhr","year":"2003","journal-title":"J Psychiatr Res"},{"key":"key\n\t\t\t\t20170624051930_awr298-B63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0893-133X(99)00095-0","article-title":"Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood\u2013brain barrier deficiency due to mdr1a P-glycoprotein gene disruption","volume":"22","author":"Uhr","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170624051930_awr298-B64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"key\n\t\t\t\t20170624051930_awr298-B65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1567205043332225","article-title":"The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease","volume":"1","author":"Vogelgesang","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"key\n\t\t\t\t20170624051930_awr298-B66","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2967\/jnumed.109.063289","article-title":"A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood\u2013brain barrier with (R)-11C-verapamil and PET","volume":"50","author":"Wagner","year":"2009","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170624051930_awr298-B67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170624051930_awr298-B68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuroimage.2008.04.251","article-title":"Simplified parametric methods for [11C]PIB studies","volume":"42","author":"Yaqub","year":"2008","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170624051930_awr298-B69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/77397","article-title":"Clearance of amyloid beta-peptide from brain: transport or metabolism?","volume":"6","author":"Zlokovic","year":"2000","journal-title":"Nat Med"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/135\/1\/181\/17863150\/awr298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T15:56:19Z","timestamp":1503417379000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awr298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,25]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,11,25]]},"published-print":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awr298","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,25]]}}}